Bivalent CAR T Cells: A New Hope for Glioblastoma
Kilder
- Nature: Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trial - Nature
- Statnews: At ASCO Day 3, AstraZeneca dominates, Takeda reveals experimental drug data, Eli Lilly serves salad - statnews.com
- Biopharmadive: AstraZeneca drug could help keep a common breast cancer at bay - BioPharma Dive
- Endpts: As life-saving checkpoint drugs move to earlier cancers, researchers debate how best to use them - Endpoints News
- Statnews: Study finds exercise can keep colon cancer from recurring - statnews.com
- Statnews: AstraZeneca’s CEO balances cancer-fighting opportunities with political uncertainty - statnews.com
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.